ClinicalTrials.Veeva

Menu

Evaluation of the Effects of Fluid Therapy on Respiratory Mechanics

U

Università degli Studi di Ferrara

Status

Unknown

Conditions

Actual Impaired Fluid Volume
Mechanical Ventilation Complication

Treatments

Drug: Cristalloid administration
Drug: Group Colloid

Study type

Interventional

Funder types

Other

Identifiers

NCT02071524
22012014

Details and patient eligibility

About

The investigators hypothesize that large doses of fluids used during intraoperative could affect lung parenchyma structure and, consequently, gas exchange and respiratory mechanics. The purpose of this study is to evaluate fluids effects on oxygenation, respiratory mechanics, by using two different solutions: crystalloid or colloid.

Full description

Inclusion Criteria:

  • patients undergoing elective abdominal, thoracic, vascular surgery
  • minimum age 18 years
  • informed consent

Exclusion Criteria:

  • patients with severe cardiomyopathy or severe heart failure
  • history of coagulation disorders
  • patients with severe cardiovascular or respiratory disorders
  • renal insufficiency

Respiratory mechanic parameters (i.e., inspiratory peak pressure, plateau pressure, total airway resistance, and static compliance) are obtained .Blood samples are drawn simultaneously from the arterial catheters for gas analysis. Data were collected after induction of anesthesia (T0) after 1 h (T1), 2 h (T2), 3 h (T3) and at the end of surgery.

Primary outcome: evaluate the fluids effects on oxygenation, respiratory mechanics

Secondary outcome: Incidence of surgery related complications

Enrollment

40 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients undergoing elective abdominal, thoracic, vascular surgery
  • minimum age 18 years
  • informed consent

Exclusion criteria

  • patients with severe cardiomyopathy or severe heart failure
  • history of coagulation disorders
  • patients with severe cardiovascular or respiratory disorders
  • renal insufficiency
  • severe liver diseases

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups

Cristalloid
Active Comparator group
Description:
group cristalloid (ringer lactate)
Treatment:
Drug: Cristalloid administration
colloids
Active Comparator group
Description:
colloid: cristalloid in according to cardiac output
Treatment:
Drug: Group Colloid

Trial contacts and locations

1

Loading...

Central trial contact

Savino Spadaro, researcher

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems